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Objective: A growing number of studies
have tested the efficacy of preventive in-
terventions in reducing the incidence of
depressive disorders. Until now, no meta-
analysis has integrated the results of
these studies.
Method: The authors conducted a meta-
analysis. After a comprehensive literature
search, 19 studies were identified that
met inclusion criteria. The studies had to
be randomized controlled studies in
which the incidence of depressive disor-
ders (based on diagnostic criteria) in an
experimental group could be compared
with that of a control group.
Results: The mean incidence rate ratio
was 0.78, indicating a reduction of the in-
cidence of depressive disorders by 22% in
experimental compared with control
groups. Heterogeneity was low to moder-
ate (I2=33%). The number needed to treat
to prevent one case of depressive disor-
der was 22. Moderator analyses revealed
no systematic differences between target
populations or types of prevention (uni-
versal, selective, or indicated). The data
included indications that prevention
based on interpersonal psychotherapy
may be more effective than prevention
based on cognitive-behavioral therapy.
Conclusions: Prevention of new cases of
depressive disorders does seem to be pos-
sible. Prevention may become an impor-
tant way, in addition to treatment, to re-
duce the enormous public health burden
of depression in the coming years.
(Am J Psychiatry 2008; 165:1272–1280)
Depressive disorders are highly prevalent (1, 2) and
have a high incidence (3), and they are associated with a
substantial loss of quality of life for patients and their rela-
tives (4, 5), increased mortality rates (6), high levels of ser-
vice use, and enormous economic costs (7–9). Major de-
pression is currently ranked fourth worldwide in disease
burden, and it is expected to rank first in disease burden in
high-income countries by the year 2030 (10).
There are two ways to reduce the enormous disease bur-
den from depressive disorders: treatment of existing disor-
ders and prevention of new cases. By far the most research
has been conducted on the treatment of depressive disor-
ders, and relatively few studies have focused on possibili-
ties for preventing the onset of new cases of depression
(11). Recent studies from Australia, however, have shown
that existing pharmacological and psychological treat-
ments cannot reduce the burden of disease of depressive
disorders by more than 35%, even under ideal circum-
stances (12, 13).
Prevention has been examined in a considerable num-
ber of intervention studies, but only a small proportion of
these have focused on possibilities for actually preventing
the onset of new cases of mental disorders (14). Most pre-
vention trials have measured change in protective factors,
such as social, cognitive, or problem-solving skills, or in
intermediate outcomes, such as severity of depressive
symptoms. In recent years, however, a growing number of
studies have examined whether prevention programs are
actually capable of reducing the incidence of cases of
mental disorders as defined by diagnostic criteria. This is
an important research question, both from a public health
perspective and from a scientific perspective. Prevention
is important because duration of the disorder is inversely
related to outcome, so that by the time cases come to the
attention of practitioners, they are harder to treat. If pre-
vention is effective, it can be employed in concert with
treatment in efforts to curtail the burden of disease associ-
ated with depression. From a scientific point of view, pre-
vention is equally interesting, as it may result in knowl-
edge about the processes leading up to the onset of
depressive disorders and how interventions may curtail or
delay these processes.
Although a growing number of studies have examined
the effects of preventive interventions on the incidence of
depressive disorders, no meta-analysis of these studies
has been conducted. An earlier meta-analysis examined
the effects of psychological prevention programs on the
incidence of all mental disorders (14). At that time, how-
ever, only a small number of studies (N=6) of the effects on
depressive disorders could be included; in the past few
years many new studies have been conducted, and in this
meta-analysis we were able to include 19 studies. We fo-
cused on the effects of preventive interventions on the in-
cidence of major depressive disorder. We also examined
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whether any factors can be identified that modify the ef-
fects of prevention.
Method
Search Strategy and Selection of Studies
We began by conducting a comprehensive literature search in
bibliographic databases for relevant articles published from 1966
to June 2007. We examined a total of 3,833 abstracts in PubMed
(N=1,205), PsycInfo (N=1,146), EMBASE (N=313), and the Co-
chrane Central Register of Controlled Trials (N=1,169). In order to
find unpublished studies, we also examined abstracts from Digi-
tal Dissertations (N=23). We searched these databases by com-
bining terms indicative of prevention and depression (specifying
searches for both MeSH terms and text words), while limiting the
search to effect studies (randomized trials, controlled trials, clini-
cal trials). Second, we examined the references of earlier reviews
and meta-analyses (14–20), and we reviewed the reference lists of
retrieved articles.
We included studies that used a pretest-posttest randomized
controlled design and examined the effects of a preventive inter-
vention on the incidence of new cases of depressive disorders
compared with a control group that did not receive the interven-
tion. To be included, studies had to use a standardized diagnostic
interview at baseline to exclude the pretest presence of a full-
blown depressive disorder and to examine the incidence of de-
pressive disorders at follow-up. We also included studies that ex-
amined interventions aimed at reducing depressive disorders as a
consequence of specific events (e.g., postnatal depression, post-
stroke depression) and did not have a pretest assessment of de-
pressive disorders but did have a posttest assessment. Studies
were excluded if they explicitly reported having included subjects
with depressive disorders who then received the intervention. No
limits were imposed on study publication language.
Quality Assessment
Although at least 25 scales are available to assess the validity
and quality of randomized controlled trials (21), there is no evi-
dence that they provide reliable assessments of validity. We there-
fore preferred to use a simple approach for assessing the validity
of the studies, as suggested in the Cochrane Handbook (21), using
three basic criteria: allocation to conditions by an independent
(third) party; blinding of assessors of outcomes; and complete-
ness of follow-up data. We did not use the fourth basic criterion
described in the Handbook (adequacy of random allocation con-
cealment to respondents), because it is inapplicable to studies
comparing psychological interventions to no-treatment control
groups.
Analyses
Because the follow-up period of the studies varied consider-
ably, we based the calculation of incidence rates on person-years.
That is, we divided the number of new cases of depressive disor-
ders that occurred during the follow-up period (the numerator)
by the total person-time units (person-years) of the group at risk
(the denominator). Technically, this is known as the person-time
incidence rate or the incidence density rate. The person-time in-
cidence rate is an appropriate measure of incidence when follow-
up times are unequal (22). In two studies, this method could not
be used because the number of subjects was larger than the num-
ber of person-years as a result of the brevity of the follow-up pe-
riod and the relatively large number of new cases during this pe-
riod. For example, when 12 persons are studied for 3 months, they
generate 4 person-years. If more than four persons develop a dis-
order during the follow-up period, the person-years incidence
rate cannot be calculated. To solve this problem, we rescaled per-
son-years into person-quarters (3 months), then combined the
study outcomes meta-analytically, and finally back-transformed
the outcome into incidence rates based on person-years. For each
study, we calculated the incidence rate ratio as the incidence rate
of developing a depressive disorder in experimental subjects rela-
tive to the incidence rate in control subjects.
To calculate pooled mean incidence rate ratios, we used the
Comprehensive Meta-Analysis software package, version 2.2.021
(Biostat, Englewood, N.J.). Because we expected considerable
heterogeneity, we conducted all analyses using the random-ef-
fects model (21), which assumes that the included studies are
drawn from “populations” of studies that differ from each other
systematically (thus exhibiting heterogeneity). In this model, the
effect sizes resulting from included studies differ because of the
random error within studies, but also because of true variation in
effect size from one study to the next.
Because our analyses were based on the assumption of an un-
derlying constant hazards model in both groups, which is not
necessarily the case, we conducted several additional analyses.
First, we calculated the odds ratio for each study (ignoring the dif-
ferences in follow-up period between the studies) and pooled
them. Second, we calculated the absolute risk differences for each
study (again ignoring the differences in follow-up period); these
risk differences were also pooled. Then we calculated the number
needed to treat, which denotes how many people would have to
receive a preventive intervention for one new case of depression
to be prevented. The number needed to treat was calculated as
the inverse of the absolute risk difference.
We also conducted a cumulative meta-analysis, in which the
results of each new study were added to the total of the studies
that had been conducted previously (23). This method allows a
determination of the point in time when the overall results of the
studies became significant.
In our analyses, we tested whether there were genuine differ-
ences underlying the results of the studies (heterogeneity) or
whether the variation in findings was compatible with chance
alone (homogeneity) (24). As an indicator of homogeneity, we cal-
culated the Q statistic. A significant Q rejects the null hypothesis
of homogeneity and indicates that the variability among the ef-
fect sizes is greater than what is likely to have resulted from sub-
ject-level sample error alone. We also calculated I2, which is an in-
dicator of heterogeneity (in percentages) not accounted for by
sample error. A value of 0% indicates no observed heterogeneity,
and larger values show increasing heterogeneity, with 25% con-
sidered low, 50% moderate, and 75% high heterogeneity, suggest-
ing that systematic factors are responsible for differences across
the effect sizes of the primary studies (24).
Subgroup and metaregression analyses were conducted ac-
cording to the procedures implemented in the Comprehensive
Meta-Analysis software. We used mixed-effects analyses, which
pooled studies within subgroups with the random-effects model
but tested for significant differences between subgroups with the
fixed-effects model.
Publication bias was tested by inspecting the funnel plot on the
primary outcome measure (incidence rate ratio) and by Duval
and Tweedie’s trim-and-fill procedure (25), which yields an esti-
mate of the effect size after the publication bias has been taken
into account (again, as implemented in the Comprehensive
Meta-Analysis program).
Results
Description of Included Studies
We retrieved a total of 135 articles that potentially met
our inclusion criteria. Of these, 116 were excluded, 81 be-
cause the presence of depressive disorders was not as-
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sessed with a formal diagnostic interview, 13 because they
were treatment and not prevention studies, 17 because
they did not examine psychological interventions, and five
for other reasons (articles that described the design of
studies without results or articles with insufficient data).
A total of 19 studies (26–44) met all inclusion criteria;
because one of these studies used three different preven-
tive interventions and a control group, a total of 21 com-
parisons could be made between a preventive interven-
tion group and a control group. The total number of
respondents in the studies was 5,806 (3,014 in the inter-
vention conditions and 2,792 in the control conditions).
Selected characteristics of the included studies are pre-
sented in Table 1.
Seven of the 19 studies were designed to prevent post-
partum depression, four dealt with prevention in school
settings, two were aimed at patients with a physical disor-
der, two focused on primary care patients, and the re-
maining studies were aimed at other target groups. Seven
studies focused on adolescents, and 12 targeted adults
(one focusing on older adults). In 14 studies, subjects with
a diagnosed depressive disorder at baseline were ex-
cluded, while the interventions in the remaining five stud-
ies (aimed at high-risk groups) did not assess the presence
of a depressive disorder at baseline. Of the 14 studies in
which subjects with a diagnosed depressive disorder at
baseline were excluded, 12 excluded those with a current
TABLE 1. Selected Characteristics of Studies Examining the Effects of Interventions on the Incidence of New Cases of
Depressive Disorders
Studya
Type of 
Preven-
tion Recruitment Target Population Inclusion Criteriab
NL: Allart-van Dam et al. 
(26) Indicated Community
Adults with subthreshold depres-
sion BDI>10; no current major depression
UK: Brugha et al. (27) Selective Screening Primiparous women Risk factor for depression 
US: Clarke et al. (28) Indicated Screening at 
schools
Adolescents (ages 15–16) CES-D Scale>24; no current major depression/
dysthymia 
US: Clarke et al. (29) Indicated Through HMO Adolescents (ages 13–18) CES-D Scale>24; >1 DSM-IV criterion; parent 
with major depression
UK: Elliott et al. (30) Selective Screening Pregnant women Vulnerable (Leverton Questionnaire) 
US: Gillham et al. (31) Indicated Through HMO Early adolescents (ages 11–12) CDI>7/9; no current major depression, 
dysthymia (K-SADS)
AU: Hagan et al. (32) Selective Screening at 
neonatal unit
Mothers of very preterm babies No current depressive disorder
SR: Martinovic et al. (33) Selective
Community + 
clinic
Adolescents (ages 13–19) with 
epilepsy
Subthreshold depression; no current depres-
sive disorder (K-SADS)
US: Muñoz et al. (34) Selective General practice 
records
General practice patients (minor-
ity; chronically ill)
No major depression in past 6 months
US: Muñoz et al. (35) Selective Screening Pregnant Latina women CES-D>16; history of major depression
AU: Priest et al. (36) Selective All women All women, after delivery No other inclusion criteria
US: Rovner et al. (37) Selective Screening in out-
patient centers
Older patients with neovascular 
macular degeneration
No current depressive disorder
US: Seligman et al. (38) Selective Screening of all 
new students
Undergraduate students Scoring in bottom quartile of the ASQ; no 
current major depression
AU: Sheffield et al. (39) Universal, 
indicated
Screening at 
school All students of 36 schools
High-symptom students (top 20% of CDI and 
CES-D); no current major depression/
dysthymia (ADIS-C)
AU: Spence et al. (40) Universal Screening at 
school
All students of 18 high schools No specific inclusion criteria
NL: Willemse et al. (41) Indicated Screening in gen-
eral practice
Adults (ages 18–65 years) One major depression core symptom; no ma-
jor depression in past 6 months
US: Young et al. (42) Indicated Screening at 
school
Adolescents (ages 15–16) CES-D Scale>16; 2 symptoms; no current ma-
jor depression/dysthymia
US: Zlotnick et al. (43) Selective
Screening in hos-
pital Pregnant women
At least 1 of 4 risk indicators of postpartum 
depression; no current major depression
US: Zlotnick et al. (44) Selective Screening in 
hospital
Pregnant women High score on risk survey; no current major 
depression (SCID-I/NP)
a AU=Australia; NL=Netherlands; SR=Serbia; UK=United Kingdom; US=United States.
b ADIS-C=Anxiety Disorders Interview Schedule for Children for DSM-IV; ASQ=Attributional Style Questionnaire; BDI=Beck Depression Inven-
tory; CES-D Scale=Center for Epidemiologic Studies Depression Scale; CDI=Children’s Depression Inventory; CIDI=Composite International Di-
agnostic Interview; K-SADS=Schedule for Affective Disorders and Schizophrenia for School-Age Children; LIFE=Longitudinal Interval Follow-
Up Evaluation; NOS=not otherwise specified; PSE=Present State Examination; SCAN=Schedules for Clinical Assessment in Neuropsychiatry;
SCID-I/NP=Structured Clinical Interview for DSM-IV Axis I Disorders—Non-Patient Edition.
c CBT=cognitive-behavioral therapy; I=indicated prevention; U=universal prevention; I+U=combined indicated plus universal prevention.
d The follow-up period is from baseline to the last follow-up measurement.
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depressive disorder and two excluded those who had a de-
pressive disorder in the previous 6 months.
We distinguished three types of prevention (45): univer-
sal prevention, such as school programs and mass media
campaigns, aimed at the general population or segments
of the general population, regardless of whether they have
a higher-than-average risk of developing a disorder; selec-
tive prevention, aimed at individuals in high-risk groups
who have not yet developed a mental disorder; and indi-
cated prevention, aimed at individuals who have some
symptoms of a mental disorder but do not meet diagnostic
criteria. Two of the 21 contrast groups we included in our
meta-analysis examined universal prevention, 11 exam-
ined selective prevention, and eight examined indicated
prevention. Fifteen interventions were cognitive-be-
havioral therapy (CBT), three were interpersonal psycho-
therapy, and the remaining were other types of interven-
tion (one-session debriefing; problem-solving; and
mutual support). In 18 comparisons, a group format was
used, and the remaining three comparisons used an indi-
vidual format. The number of sessions ranged from one to
15.
The follow-up periods in the different studies ranged
from 3 to 36 months. Ten studies were conducted in the
United States, four in Australia, two in the United King-
dom, two in the Netherlands, and one in Serbia.
Although the quality of the included studies was rela-
tively high, the criteria assessing the validity of the studies
did not indicate very positive results. Only seven studies
reported allocation to conditions by an independent
Prevented Disorderb Conditionsc Interventionc
Follow-Up 
(months)d
Dropout 
Rate (%)
Intention-
to-Treat 
Analysis
Major depression (CIDI) CBT (N=61) and care as usual (N=41) 12 group sessions CBT (2 hours) 12 25 Y
Postpartum depression 
(SCAN)
CBT (N=94) and care as usual (N=96) 6 group sessions CBT + problem 
solving, social support
3 9 N
Major depression, dysthymia 
(K-SADS)
CBT (N=55) and care as usual (N=70) 15 group sessions CBT (45 min) 12 27 N
Major depression, dysthymia 
(K-SADS)
CBT (N=43) and care as usual (N=47) 15 group sessions CBT (1 hour) 24 17 N
Postpartum depression (PSE) Psychoeducation (N=47) and care as 
usual (N=52)
11 group sessions psychoeduca-
tion + mutual support
3 15 Y
Major depression, 
dysthymia, depressive 
disorder NOS
CBT (N=147) and care as usual 
(N=124)
12 group sessions CBT (90 min; 
Penn Resilience Program)
24 41 Y
Postpartum depression CBT (N=101) and care as usual (N=98) 6 group sessions CBT + psychoed-
ucation (2 hours)
12 12 Y
Major depression CBT (N=15) and care as usual 
(counseling) (N=15)
12 group sessions CBT 9 6 N
Major depression, dysthymia CBT (N=72) and care as usual (N=78) 8 weekly group CBT sessions (2 
hours)
24 8 N
Postpartum depression CBT (N=21) and care as usual (N=20) 12 weekly group CBT sessions 12 9 N
Postpartum depression (ma-
jor or minor depression)
Debriefing (N=875) and care as usual 
(N=870)
One debriefing session within 3 
days after delivery
12 1 Y
Major or minor depression 
(SADS)
Problem-solving therapy (N=105) and 
care as usual (N=101)
6 sessions problem-solving ther-
apy (45–60 minutes) 6 13 Y
Major depression CBT (N=106) and care as usual 
(N=119)
8 weekly group CBT sessions (2 
hours)
36 4 N
Major depression, dysthymia CBT-U (N=107); CBT-I+U (N=100); 
CBT-I (N=110); and care as usual
(N=125)
8 group sessions CBT + problem-
solving therapy (45–50 min)
18 16 Y
Major depression (ADIS-C) CBT (N=751) and care as usual 
(N=749)
8 group sessions CBT + problem-
solving therapy (45–50 min)
12 15 N
Major depression, dysthymia 
(CIDI)
CBT (N=107) and care as usual (N=
109)
Minimal contact CBT; 1  face-to-
face contact + self-help book + 
6 brief telephone consultations 12 37 Y
Major depression, dysthymia 
(K-SADS)
Interpersonal therapy (N=27) and 
care as usual (N=14)
2 individual + 8 group sessions of 
interpersonal therapy
6 2 Y
Postpartum depression Interpersonal therapy (N=17) and 
care as usual (N=18)
4 weekly group sessions interper-
sonal therapy
3 5 N
Postpartum depression 
(LIFE)
Interpersonal therapy (N=53) and 
care as usual (N=46)
4 group sessions interpersonal 
therapy
3 13 N
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party. Blinding of assessors of outcomes was reported in
eight of the 19 studies. Dropout rates ranged from 1% to
41%. In nine studies, intention-to-treat analyses were con-
ducted.
Incidence Rate Ratios
The mean incidence rate ratio for all 21 comparisons
from the 19 studies was 0.78 (95% confidence interval
[CI]=0.65–0.93), which was significant (p<0.01). Heteroge-
neity was low to moderate (Q=29.77, p<0.10; I2=32.81%).
The results of this meta-analysis are summarized in Table
2 and Figure 1. The cumulative meta-analysis showed that
the overall results became significant after the first four
studies had been published in 2000 (Figure 1).
Because the weight of one study (36) was very high
(34.2%), and because this was also the study in which a
very different type of intervention was used (one-session
debriefing after childbirth), we examined whether re-
moval of this study from the analysis would change the
overall results. The resulting mean incidence rate ratio was
0.74 (95% CI=0.61–0.90, p<0.01), with low heterogeneity
(Q=25.69, n.s.; I2=26.05%), which is comparable to the in-
cidence rate ratio found in the analyses with the full sam-
ple.
In one large study (39), three intervention conditions
were compared with one control group. Because these
three comparisons were not independent from each other,
we examined whether removal of these comparisons
would increase heterogeneity. The resulting mean inci-
dence rate ratio was 0.74 (95% CI=0.59–0.92, p<0.01; Q=
28.79, p<0.05; I2=40.95%).
Neither the funnel plots nor Duval and Tweedie’s trim-
and-fill procedure suggested a significant publication
bias. The incidence rate ratio did not change after adjust-
ment for possible publication bias (the observed and ad-
justed effect sizes were the same).
Risk Differences and Number Needed to Treat
Our analyses were based on the assumption of an un-
derlying constant hazards model in both groups, which
may not be the case. We conducted several sensitivity
analyses. We calculated the odds ratio for each study (ig-
TABLE 2. Meta-Analyses of Studies Examining the Effects of Preventive Interventions on the Incidence of Depressive Disor-
ders: Incidence Rate Ratios, Risk Differences, and Number Needed to Treat
 
Analysis and 
Variable
Number 
of Com-
parisons
Analysis of Incidence Rate Ratios (IRRs) Analysis of Risk Differences Number 
Needed 
to TreataIRR 95% CI z Q I2 (%)
Risk Dif-
ferences 95% CI z
Overall analyses
All studies 
included 21 0.78 0.65 to 0.93 –2.73** 29.77 32.81 –0.045 –0.073 to –0.016 –3.08** 22
1 high-weight 
study (36) 
excluded 20 0.74 0.61 to 0.90 –2.99** 25.69 26.05 –0.054 –0.087 to –0.022 –3.28** 19
Subgroup 
analyses
Type of 
preventionb
Universal 2 0.90 0.61 to 1.33 –0.52 1.10 8.95 0.003 –0.018 to 0.024 0.27
Selective 11 0.72 0.54 to 0.97 –2.19* 17.78 43.73 –0.062 –0.108 to –0.016 –2.63** 16
Indicated 8 0.76 0.55 to 1.05 –1.67 10.50 33.34 –0.059 –0.108 to –0.009 –2.33* 17
Target group
Postpartum 
women 7 0.65 0.41 to 1.05 –1.77 14.96* 59.89 –0.072 –1.41 to –0.002 –2.03* 14
School 6 0.83 0.61 to 1.12 –1.21 6.52 23.34 –0.021 –0.063 to 0.021 –0.97 48
Other 8 0.77 0.61 to 0.97 –2.24* 6.92 0.00 –0.053 –0.096 to –0.010 –2.42* 19
Age group
Adolescents 9 0.77 0.57 to 1.04 –1.69 12.30 34.96 –0.047 –0.097 to 0.002 –1.88 21
Adults 12 0.77 0.60 to 0.98 –2.14* 17.35 36.59 –0.050 –0.089 to –0.010 –2.46* 20
Major depression 
excluded at 
baseline
Yes 16 0.78 0.64 to 0.95 –2.48* 17.62 14.86 –0.051 –0.083 to –0.019 –3.11** 20
No 5 0.72 0.46 to 1.13 –1.42 10.71* 62.64 –0.031 –0.079 to 0.017 –1.26 32
Interventionc
CBT 15 0.84 0.71 to 1.00 –2.00* 12.85 0.00 –0.024 –0.049 to 0.000 –1.95 42
Interpersonal 
therapy 3 0.14 0.05 to 0.44 –3.39** 0.51 0.00 –0.212 –0.318 to –0.106 –3.92*** 5
Other 3 0.76 0.47 to 1.20 –1.18 6.16* 67.52 –0.057 –0.158 to 0.044 –1.11 18
Format
Group 18 0.74 0.59 to 0.92 –2.65** 25.32 32.87 –0.055 –0.091 to –0.019 –3.02** 18
Individual 3 0.90 0.70 to 1.17 –0.77 2.51 20.40 –0.016 –0.059 to 0.027 –0.72 63
a Numbers needed to treat with a value of zero or less are not reported.
b Comparison of risk differences between subgroups significant at p<0.01.
c Comparison of incidence rate ratios significant at p<0.05, and comparison of risk differences significant at p<0.01.
*p<0.05; **p<0.01; ***p<0.001.
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noring the differences in follow-up period between the
studies) and pooled them. The resulting odds ratio was
0.76 (95% CI=0.62–0.94; z=–2.59, p=0.01), which was com-
parable to the earlier analyses.
We also calculated the absolute risk differences for each
study (again ignoring the differences in follow-up period).
This resulted in a pooled risk difference of –0.045 (95% CI=
–0.073 to –0.016, p<0.01), which corresponds to a number
needed to treat of 22 (Table 2). The numbers needed to
treat for each study are presented in Figure 1.
Subgroup and Metaregression Analyses
Because some heterogeneity was observed, we con-
ducted a series of subgroup and metaregression analyses.
The results of the subgroup analyses are presented in Ta-
ble 2. We examined whether the incidence rate ratio dif-
fered according to type of prevention (universal, selective,
or indicated), target group (postpartum depression, stu-
dents, or other), and age group (adolescents or adults). We
also examined whether the studies in which subjects with
a depressive disorder were excluded at baseline differed
significantly from those in which high-risk groups were in-
cluded without the exclusion of diagnosed cases. Then we
examined whether type of intervention (CBT, interper-
sonal psychotherapy, or other) and format of the interven-
tion (group or individual) were related to the incidence
rate ratio.
As indicated in Table 2, the incidence rate ratio differed
significantly in only one subgroup. Studies in which inter-
personal psychotherapy was used as an intervention ap-
peared to be significantly more effective than those in
which CBT or other interventions were used. Given the
small number of comparisons (N=3) examining interper-
sonal psychotherapy, however, these results should be in-
terpreted with caution.
In most of the subgroup analyses, heterogeneity was low
or low to moderate. The subgroups of studies using CBT
interventions or interpersonal psychotherapy showed no
evidence of heterogeneity. Studies using other interven-
tions had moderate to high heterogeneity, as might have
been expected.
We conducted the same subgroup analyses based on
the risk differences. As indicated in Table 2, the type of in-
tervention was again found to be associated with signifi-
cant differences between subgroups. However, in these
FIGURE 1. The Effects of Preventive Interventions on the Incidence of Depressive Disorders: Incidence Rate Ratios and
Numbers Needed to Treata
a NNT=number needed to treat; n/Nexp=number of incident cases among the total group of subjects in the experimental condition; n/Nctr=
number of incident cases among the total group of subjects in the control condition; IRR=incidence rate ratio. 
b Numbers needed to treat with a value of zero or less are not reported.
c I=indicated prevention; U=universal prevention; I+U=combined indicated plus universal prevention.
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    9.33        12          3/21         5/20      
  32.89        18        24/110     26/125     
           b                   18        19/621     26/605
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analyses, we also found that the different types of preven-
tion (universal, selective, or indicated) differed signifi-
cantly from each other (p<0.01).
Because universal prevention appeared to differ signifi-
cantly from selective and indicated preventions, and pre-
vention based on interpersonal psychotherapy differed
significantly from the preventions used in the other stud-
ies, we conducted another subgroup analysis in which we
excluded the two comparisons based on universal preven-
tion and the three comparisons based on interpersonal
psychotherapy. The resulting incidence rate ratio was 0.82
(95% CI=0.70–0.98, p<0.05; Q=18.28, n.s.; I2=17.92%), and
the risk difference in this subgroup of studies was –0.035
(95% CI=–0.063 to –0.007, p<0.05; Q=18.93, n.s.; I2=
20.74%). The pooled odds ratio (in which we ignored the
differences in follow-up period between the studies) was
0.81 (95% CI=0.67–0.98, p<0.05).
We conducted a metaregression analysis to examine the
relationship between incidence rate ratio and follow-up
period. We found that the follow-up period was inversely
related to the incidence rate ratio, although the association
did not reach statistical significance (p<0.10; the point esti-
mate of the slope was –0.023; 95% CI=–0.050 to 0.004). This
result can be interpreted as an indication that the effects of
the intervention become smaller over longer follow-up
periods, which may indicate that the preventive interven-
tions delay the onset of disorders rather than preventing
them altogether. We also conducted a metaregression
analysis to examine whether the incidence rate ratio was
related to the number of sessions used in the preventive
intervention, but no significant relationship was found.
Discussion
We found clear indications that preventive interven-
tions can significantly reduce the incidence of depressive
disorders by 22% compared with treatment-as-usual con-
trol groups. This means that prevention should perhaps
have a larger role in the further reduction of the disease
burden of depressive disorders.
Although preventive interventions appear to be effec-
tive in reducing the incidence of depressive disorders, the
numbers needed to treat seem to be rather high (22 in the
overall analysis). On the other hand, there are no clear
guidelines for what is a high number needed to treat and
what is not (46). For example, the regular use of aspirin to
reduce the risk of heart attack has become common prac-
tice, and the number needed to treat has been found to be
130 (46, 47). The number needed to treat associated with
the use of cyclosporine in the prevention of organ rejec-
tion has been found to be 6.3 and is considered a medical
breakthrough of considerable practical importance. A
number needed to treat of 22 to prevent the onset of a de-
pressive disorder does not seem unreasonably high, and it
is even more favorable if we focus on selective (number
needed to treat=16) and indicated prevention (number
needed to treat=17).
We found no evidence that the capability of preventive
interventions to reduce the incidence of major depression
depends on use of specific target groups, such as women
at risk of postpartum depression and school interventions
directed at students. We did find indications that universal
interventions were less effective than selective and indi-
cated interventions. However, universal interventions
were examined in only two studies, and pooling of these
studies or a comparison with selective or indicated inter-
ventions is not very meaningful. The mean incidence rate
ratio for universal interventions was not significant and
approached a value of 1.0, indicating an absence of effect.
Selective (incidence rate ratio=0.72) and indicated in-
terventions (incidence rate ratio=0.76) had comparable
effects. These findings are in agreement with a recent
meta-analysis of preventive interventions aimed at de-
pression in children and adolescents (20). Although that
study examined the effects on depressive symptom sever-
ity rather than on incidence of depressive disorders, clear
indications were found that selected and indicated pro-
grams had larger effects than universal programs.
We also found some indications that interventions us-
ing interpersonal psychotherapy were more effective than
those using CBT. This result must be considered with cau-
tion, however, because interpersonal psychotherapy-
based interventions were examined in only three studies.
Furthermore, in a recent study of a preventive interven-
tion aimed at adolescents, interpersonal psychotherapy
and CBT interventions resulted in comparable effect sizes
(48). If interpersonal psychotherapy-based interventions
are indeed more effective, this may be related to the fact
that this type of intervention focuses more directly on ex-
isting problems and high-risk situations than does CBT.
For people in high-risk situations or with subthreshold
symptoms, this may be exactly what they need.
It is not clear whether the preventive interventions actu-
ally reduced the incidence or only delayed onset. Because
the follow-up period in most studies did not exceed 2
years, it cannot be concluded that incidence was actually
prevented. In fact, we found that the length of the follow-
up period was inversely associated with the incidence rate
ratio; although not statistically significant, this relation-
ship can be seen as an indication of effect decay over time,
which could point to a delay of incidence rather than pre-
vention. From a clinical perspective, both preventing and
delaying onset are important. Actual prevention of new
cases would of course be preferable, as it would result in
avoidance of the disease burden of all prevented cases.
Delay of onset is also important, however, because the dis-
ease burden of depression is high. Every year during which
a potential depressive disorder can be avoided will result
in considerably less suffering by patients and their fami-
lies and may entail a reduction in economic costs.
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This study had several limitations. First, the number of
studies examining the effects of preventive interventions
on the incidence of depressive disorders was relatively
small, and the quality of the included studies was not op-
timal. Also, the included studies examined several differ-
ent interventions and target populations. However, heter-
ogeneity in our sample of studies was low to moderate,
indicating that this may be a fairly homogeneous group of
studies. The differences in follow-up periods across the
studies constitute another limitation. To try to overcome
this limitation, we calculated the number of new cases
during follow-up in terms of person-time-based incidence
rate ratios, but this approach assumes that the occurrence
of new onsets was distributed evenly over the follow-up
period. This assumption of an underlying constant haz-
ards model in both groups may not be correct and may
have resulted in an underestimation of the incidence rate
ratio in the studies with longer follow-up periods or an
overestimation in those with shorter follow-up periods.
On the other hand, our sensitivity analyses indicated that
our results were quite robust and that the underlying con-
stant hazards model is probably acceptable for the rela-
tively brief follow-up periods of the included studies. Be-
cause of these limitations, the results of this study should
be considered with caution.
It is encouraging to find that prevention of new cases of
depressive disorders seems to be feasible. Prevention may
be an important way, in addition to treatment, to reduce
the enormous burden of depression in the coming years.
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